Arbutus Biopharma Corp (ABUS)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

ABUS logo

ABUS Deferred Revenue

Latest reported$0.00
ABUS Quarterly Deferred Revenue ($6.38M → $0.00)
High-resolution chart · PNG

ABUS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
6,759,000
7,571,000
10,911,000
11,034,000
0
11,791,000
0
0
0
16,456,000
0
16,973,000
23,255,000
0
0
0
0
0
0
0
0
0
7,002,000
7,597,000
5,466,000
0
649,000
974,000
1,720,000
2,742,000
15,000
2,624,000
2,624,000
15,000
15,000
711,000
924,000
868,000
4,835,000
5,605,000
5,233,000
5,779,000
4,877,000
6,043,000
5,621,000
3,463,255
4,317,152
3,765,716
4,347,688
3,143,882
3,131,664
2,999,058
3,135,902
2,750,144
2,508,606
3,071,421
2,457,425
1,981,946
5,413,097
4,894,394
1,266,207
1,110,148
2,848,110
1,901,646
752,631
377,234
1,363,467
2,704,011
3,356,904
4,652,141
5,774,252
6,377,963
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.